Company news
SkinBioTherapeutics PLC news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Conversion Notice & Total Voting Rights
April 5, 2024
New research project and CSO to return to academia
March 18, 2024
Conversion notice and alternative financing
February 28, 2024
Positive Interim AxisBiotix Acne study results
February 27, 2024
Dermatonics to launch Once Heel Balm in AMEA
February 20, 2024
Dermatonics Full Year trading update
February 6, 2024
Completion of Acquisition of Dermatonics
January 26, 2024
Acquisition of Dermatonics
January 25, 2024
Update on transaction timelines to early 2024
December 29, 2023
Notice of AGM and posting of Annual Report
December 6, 2023
AxisBiotix-Ps™ to launch on Amazon UK
November 30, 2023
Update regarding Nominated Adviser and Broker
November 22, 2023
Result of Retail Offer
November 21, 2023
Result of Placing
November 17, 2023
Retail Offer
November 16, 2023
Acne study, Trading and Auditor updates
October 25, 2023
Extension of Croda contract for SkinBiotix™
October 19, 2023
health authority approval for AxisBiotix in France
September 15, 2023
Update on acne programme
September 5, 2023
Regulatory Approval
June 21, 2023
Business progress update
June 14, 2023
SkinBiotix and AxisBiotix Update
May 10, 2023
Director/PDMR Shareholding
April 14, 2023
Replacement Half-year Report
March 28, 2023
Price Monitoring Extension
March 27, 2023
AxisBiotix-PsT approved for launch in Europe
March 7, 2023
Result of General Meeting
January 31, 2023
Second Price Monitoring Extn
January 16, 2023
Notice of General Meeting - Replacement
January 6, 2023
Results of AGM
December 30, 2022
Report and Accounts, and Provision Update
December 23, 2022
SkinBioTherapeutics will 'continue to be flexib...
December 19, 2022
REX Retail Offer
December 15, 2022
Notice of AGM
December 6, 2022
Update of oral programme and trading
August 31, 2022
Stmnt re Share Price Movement
June 13, 2022
Change of Registered Office
May 26, 2022
Confirmation of Directorate Appointments
April 27, 2022
Investor Presentation - Interim Financial Results
March 22, 2022
Business update
February 17, 2022
Grant of share options
January 12, 2022
Annual General Meeting 2021 - Change of Venue
December 21, 2021
Full year results
November 30, 2021
Placing of Shares
November 15, 2021
Commercial Launch of AxisBiotix-PsT
October 29, 2021
Investor Presentation
October 15, 2021
AxisBiotix-PsT Psoriasis Food Supplement Launch
September 30, 2021
Business Update - Correction
August 19, 2021
Positive data for AxisBiotix-PsT consumer study
May 26, 2021
Initiation of oral health development programme
April 27, 2021
Calls
The 5 newest of 8 calls. Every call is listed under its year.
- SkinBioTherapeutics (LSE:SBTX) — Investor Presentation
Jun 29, 2026
Transcript - SkinBioTherapeutics (LSE:SBTX) — Superdrug Commercial Agreement
Jul 3, 2025
Transcript - SkinBioTherapeutics (LSE:SBTX) — Half Year results for the six months ended 31 December 2024 & Launch
Apr 16, 2025
Transcript - SkinBioTherapeutics (LSE:SBTX) — Full Year Results
Dec 10, 2024
Transcript - SkinBioTherapeutics (LSE:SBTX) — Investor Presentation
Jul 29, 2024
Transcript